We have been exploring techniques for evaluation of fluoro-deoxyglucose (FDG) utilization characteristics in human sarcomas measured with positron emission tomography. In previous work, a measure of spatial heterogeneity based on evaluating the deviation of the FDG utilization distribution within the tumor region from a unimodal elliptically contoured spatial pattern was developed. This measure was shown to be a strong prognostic indicator of time to death. The present work explores a more general measure of heterogeneity which incorporates tumor boundary information. The approach relies on the use of a non-parametric representation for the tumor boundary surface. A set of 179 sarcoma patients with follow-up are evaluated with this technique. The results are analyzed to obtain empirical insight into the factors explaining elliptical heterogeneity. In terms of patient survival, the incorporation of the more sophisticated measure of spatial heterogeneity shows some potential improvement in the prediction risk. Further data will enable us to obtain a clearer empirical understanding of the role of the surface information in the measurement of tumor heterogeneity.
INTRODUCTION
Sarcomas are a diverse class of tumors affecting soft tissue, cartilage and bone. Treatment involves surgical resection preceded, depending on the histologic grade, by chemotherapy. The median survival time for patients is about 5 years from the time of surgery. A clinical study at the University of Washington (the major treatment center for sarcoma in the Pacific Northwest) is using positron emission tomography (PET) scanning to obtain 3-D local fluoro-deoxyglucose (FDG) utilization surveys of tumors prior to treatment. A database with several hundred cases has been obtained so far. Analysis of these data provides the opportunity to identify refined prognostic indicators of tumor status which may ultimately lead to improvements in patient care. Interim results reported by Eary et al. (2002) have found that the maximum standardized uptake value (SUV max ), a scaling of the FDG data, within the tumor is an independent prognostic indicator of death and is a more reliable indicator of prognosis than the conventional grading obtained from sampling by biopsy prior to treatment or even post-surgical histologic evaluation of the resected tumor mass (Eary et al., 2002) .
There is typically wide variation in the distribution of FDG uptake within a sarcoma. It is thought that this variation is a key factor in determining tumor progression. A variable tumor mass is likely to contain a more diverse collection of cancer cells which might be best treated with different therapies. Application of a uniform treatment may eliminate one type of cancer cell but in a variable tumor may leave other cell types largely intact, ultimately contributing to the progression of the disease. The amenability of the tumor to surgical resection is also important. In this context, a tumor which has a simple compact form is easy to resect but a diffuse mass presents a more difficult challenge for the surgeon. In previous work, we developed a measure of heterogeneity (H E ) for sarcomas which was based on the departure of the FDG utilization within the tumor volume from a simple ellipsoidal pattern (O'Sullivan et al., 2003) . Using a set of 74 patients with follow-up survival information, this heterogeneity measure was found to have a strong association with survival. In fact, a multivariate stepwise Cox regression analysis including standard prognostic factors as well as a range of alternative PET-based measures (including volume, relative dispersion (RD) and SUV max ) retained only heterogeneity and SUV max as significant prognostic indicators of survival. Of these two variables, H E was found to have the strongest association with survival. Since the H E measure of heterogeneity evaluates departure from an ellipsoidal pattern of FDG utilization, one could argue that if the tumor volume is highly non-elliptical H E may be high even though the FDG utilization within the tumor is quite uniform. The work reported here explores an alternative measure of heterogeneity which incorporates information about tumor shape. The computation of the new measure makes use of a non-parametric surface representation for the tumor boundary. Data from a set of 179 sarcoma patients enable us to obtain an empirical understanding of the heterogeneity measure and its relation to patient survival. The boundary-adapted measure of spatial heterogeneity shows some potential improvement over H E in the prediction risk. In fact, a multivariate Cox regression analysis identifies the shape-based heterogeneity as having the strongest association with time to death.
The elliptical measure of heterogeneity measure is reviewed in Section 2 and generalizations which incorporate the tumor boundary structure are introduced. The computational aspects of the generalizations are also presented. These include a description of the non-parametric estimation procedure used for representation of the tumor boundary surface. The techniques are illustrated in Section 3 and analysis carried out on a set of 179 sarcoma patients for which heterogeneity measures have been computed. The paper con cludes with some discussion.
METHODOLOGY
We consider a data set which consists of an array {(z i , w i, x i ), i = 1, 2, . . . , I } corresponding to measurements of the glucose utilization (z), its associated precision/weight (w) and the 3-D spatial co-ordinate (x) for I tissue volume elements (voxels) in the region of interest (ROI), ⊂ R 3 . Heterogeneity is defined as a measure of the departure of the observed utilization data in the ROI from an idealized structure. The idealized structures we consider are motivated by the sarcoma application and are given by
where t (·|θ) is a contour co-ordinate function and l is a monotone decreasing level function. The contour co-ordinate function is a mapping t (x|θ): → [0, 1] controlled by a set of finite dimensional parameters θ . These parameters are optimized by weighted least squares to obtain the best fitting idealized structure to the ROI data. Thus, the optimal parametersl andθ satisfy
Heterogeneity (H ) is defined as the fraction of the total weighted sum of squares that is unexplained by the fitted idealized structure. Ifẑ i =l(t (x i |θ), for i = 1, 2, . . . , I , are the glucose utilization values predicted by the best fitting idealized structure, the heterogeneity is given by
Obviously, heterogeneity must always lie in the interval [0, 1] . If the utilization is uniform in the ROI, then l can be made arbitrarily close to a constant so that the heterogeneity will be zero. Different choices for the contour co-ordinate function lead to different measures of heterogeneity. The present work compares boundary-adapted contours with simple elliptical ones. We have included weights in the above, although this was not contained in the original formulation (O'Sullivan et al., 2003) . In the context of our PET studies we use uniform weights, but it is likely that techniques for construction of weights (Carson et al., 1993) will eventually become incorporated into operational PET scanning. Thus, the formulation using general weights is of potential interest.
Alternative contour co-ordinate functions and heterogeneities
For the elliptical heterogeneity measure (O'Sullivan et al., 2001 (O'Sullivan et al., , 2003 ) the contour co-ordinate function is specified as
where θ = (µ, ) includes a location parameter µ and a 3 × 3 symmetric positive matrix . The proportionality constant is set so that max x∈ t e (x|θ) = 1. The heterogeneity measure associated with the ellipsoidal contours is denoted by H E . An alternative to the elliptical heterogeneity is obtained by considering contour co-ordinate functions which are adapted to the tumor boundary. We consider representations of the boundary which are described by a 2-D star-shaped surface. This is motivated by the structure of typical sarcoma tumor regions, which often present as convex regions. A star-shaped surface centered at the origin is defined in terms of a polar radius functionr (φ, ϕ):
be the Euclidean co-ordinate corresponding to the spherical polar co-ordinate (φ, ϕ,r (φ, ϕ)),
The surface associated with the polar radius functionr (φ, ϕ) is given by the set {v(φ, ϕ)
This surface can be shifted, scaled and rotated. Using a location parameter µ and a 3 × 3 symmetric positive matrix we can produce the surface
A contour co-ordinate function associated with the surface S(µ, ) can now be defined. For any x ∈ we let (φ x , ϕ x , r x ) be the spherical polar co-ordinates of v x = −1/2 (x − µ) and define the contour co-ordinate function value by
.
As with the elliptical contour co-ordinate function, the proportionality constant is set so that max x∈ t s (x|θ) = 1. Note that, the parameterization of a contour co-ordinate function t s (x|θ) is not unique. Two contour co-ordinate functions which are the same may have different covariance matrices and polar radius functions. To remove this ambiguity, we require to be pre-specified. Here, we take from an analysis of elliptical heterogeneity. The heterogeneity measure associated with the surface S is denoted H S . Note that withr (φ, ϕ) = 1, t s (x|θ) reduces to the ellipsoidal form t e (x|θ), i.e. with S = S(µ, , 1), t s (x|θ) = t e (x|θ) and H S and H E coincide. The idealized structure corresponds to H S having contours which mimic the boundary surface throughout the ROI. As a generalization of this pattern, we can allow the contours to become more elliptical toward the center of the tumor. A one-parameter family of such contours can be constructed as follows: for α > 0, let u α (x) = t s (x|θ) α and
Since u α (x) → 0 as x → µ and u α (x) tends to 1 as x approaches the boundary, t g (x|θ, α) will have an elliptical pattern toward the center and will adapt to the surface contour at the boundary. The parameter α controls the rate of transition from the surface contour to the elliptical contour. For small α the elliptical pattern dominates while for large α the surface contours will dominate. Figure 1 illustrates the situation for a particular choice of α. The corresponding elliptical co-ordinate function is shown for reference. The definition of heterogeneity based on the generalized contour co-ordinate function involves the optimization of α and θ as well as the level function. For ease of notation we incorporate α as a component of θ . Once this optimization has been carried out, the corresponding heterogeneity (denoted H G ) is evaluated according to (2.3).
Computation
For evaluation of heterogeneity, we consider the weighted residual sum of squares criterion
When the contour function depends on the surface, there is a non-uniqueness associated with the covariance and the polar radius function. As indicated previously, we use the covariance matrix associated with the elliptical heterogeneity analysis. Thus, θ = µ for the surface boundary contour model. For any fixed µ the tumor boundary voxels are used to construct a non-parametric estimate of the surface,Ŝ µ . The technique used to achieve this is discussed below. The optimization of the weighted residual sum of squares over monotone choices of l is readily computed using the classical algorithm of Barlow et al. (1972) implemented in the freely available code of Brown (1989) . Thus, the weighted residual sum of squares criterion is reduced to a function of µ alone.
(2.5)
Following the development of the elliptical case (O'Sullivan et al., 2003) , the code of Dennis et al. (1981) is used for optimization over µ. General conditions for the convergence of the Gauss-Newton algorithm used in the code of Dennis et al. (1981) are well documented. Given the substantial non-linearities, it is difficult to check if those conditions hold in practice. But our experience with the scheme, based on many applications to real and simulated data sets, has been highly satisfactory, with numerical convergence typically occurring in fewer than 10 iterations for all the data sets we have examined. For the generalized contour co-ordinate function, we consider contour co-ordinate functions given by
whereû α (x) = t s (x|θ S ) α andθ e andθ S are the optimized elliptical and boundary contour parameters, respectively. The optimization of the weighted residual sum of squares is based on a 1-D grid search over alternative values of α. For each value of α, the optimal monotone decreasing level function is again computed using the code of Brown (1989) .
Surface boundary estimator
Let {x b , b = 1, 2, . . . , I B } be the co-ordinates of the tumor boundary voxels and let (φ b , ϕ b , r b ) be the spherical polar co-ordinates of v b =ˆ (µ) −1/2 (x b − µ) for b = 1, 2, . . . , I B . A kernel smoothing procedure is employed to estimate the polar radius function. The estimation formula is
In order to account for the local surface area of grid pixels, the local bandwidth of kernel function varies with latitude. Thus,
where K lat and K lon are 1-D Gaussian convolution kernels in latitude and longitude. The longitude component of the kernel is periodic but the latitude component is not. Notice that the standard deviation of the longitude component of the kernel varies according to latitude as σ (φ) = σ 0 /cos(φ). The equatorial latitude corresponds to φ = 0 so σ (0) = σ 0 . The kernel is rotationally invariant at the equator and the value of σ 0 is chosen so that the full-width at half the maximum of the kernel is h (radians) at the equator. The amount of smoothing is adapted to the data by means of generalized cross-validation (Wahba, 1990 ). This criterion is
is the residual sum of squares. d f (h) is an expression for the degrees of freedom of the smoother. In the present context, we use a formula based on the influence matrix associated with the kernel estimator
(2.9)
The deviation between the tumor boundary co-ordinates and their predictions based on fitted polar radius function, i.e. WRSS(r h )/I B , provides an evaluation of the degree of star-shapedness of the ROI. The particular choice of smoothing technique used has the advantage of computational simplicity but could be replaced by other statistical surface smoothing techniques, should they become available.
3. APPLICATION TO PET SARCOMA DATA Heterogeneity values were calculated for a set of 179 sarcoma studies analyzed for FDG utilization with PET at the University of Washington. Each PET study produced a volume with between 35 and 105 image planes with 128 × 128 voxels in each image. Tumor regions were identified in collaboration with an oncologist, with reference to conventional diagnostic CT or MRI scans. The tumor regions varied in size between 200 and 50 000 voxels. For the set of 179 studies all three heterogeneities were computed in a total of 36 hours on a dedicated 2.8 GHz workstation. Computations for the surface heterogeneity were more time consuming-about five times greater than the elliptical heterogeneity calculations. After H E and H S were calculated, the computation of the generalized measure H G required very little additional time. Results of the heterogeneity analysis for two tumors are shown in Figure 2 . One of the tumors is relatively homogenous while the other is more heterogeneous. In both cases the boundary shape is seen to show departure from a simple elliptical pattern. However, the assessments of heterogeneity by all three methods are quite close to each other as shown in Figure 2 . Figure 3 plots the relative deviations between the surface heterogeneity (H S ) and the elliptical heterogeneity (H E ). The two measures have a correlation in excess of 95% and the absolute relative difference between the two is less than 8% for 90% of the tumors. We examined the relationship between elliptical heterogeneity and other factors, including tumor morphology and the RD of the glucose utilization within the tumor region. The morphological descriptors of the tumor region considered included volume, ellipticity as measured by the fit of the tumor surface boundary by a simple ellipsoidal contour and a fractal measure of the tumor boundary, namely the ratio of the square root of the number of boundary voxels to the cubed root of the tumor volume. Figure 3 shows a log-linear relation between elliptical heterogeneity and tumor volume. A regression analysis shows that the elliptical heterogeneity is associated with tumor volume and RD. Almost 60% of the variability in the logarithm of elliptical heterogeneity is explained by a linear combination of the logarithm of tumor volume (Vol) and the logarithm of RD. Both quantities are highly significant explanatory variables. Inclusion of the logarithm of surface heterogeneity into this regression increases the percentage of variance explied to 93%. RD continues to be statistically significant while the p-value for volume is 0.064. However, the practical importance, as measured by the standardized regression coefficients, of RD and volume is not substantial.
Explanation of elliptical heterogeneity

Evaluation as predictors of survival
In the context of this application, the most important consideration is the relation between heterogeneity, and other potential risk factors, on patient outcome. An analysis of elliptical heterogeneity was previously reported in O'Sullivan et al. (2003) . This analysis was based on N = 74 patients with follow-up. We have extended this analysis to the larger sample here in which we have an additional 1.5 years of follow-up, giving N = 179 patients with 71 events (deaths). A multivariate Cox proportional hazards survival analysis has been employed to explore the role of three characterizations of heterogeneity as well as a number of other variables of interest in predicting risk of death. Age and SUV max have been included in all our analyses to facilitate comparison with previous work reported in Eary et al. (2002) and O'Sullivan et al. (2003) . Table 1 reports the results of an analysis in which age, SUV max , RD, Vol, H E , H S and H G are jointly considered. In order to simplify the interpretation, variables are sequentially adjusted by means of linear regression. Here an adjusted variable is defined as the residual from the regression of the variable under consideration on a set of the adjustment factors. In Table 1 , SUV max is adjusted for age, RD is adjusted for age and SUV max , etc. and finally H G is adjusted for age, SUV max , RD, Vol, H E and H S . These adjustments enable us to better appreciate the new information provided by the increasingly more complex quantifications of the PET data. The p-value for volume (Vol) in Table 1 is large while that for heterogeneity (H E ) is highly significant. Thus, although Figure 3 indicates a strong rank correlation between heterogeneity and volume, the adjustment process shows that there is little information about survival in volume that is not already captured in age, SUV max and RD. In contrast, even after adjustment for age, SUV max , RD and Vol, heterogeneity has an important association with patient survival. All variables in Table 1 are standardized, so the estimated log-hazard model coefficients, β, can readily be converted, using the transformation 100 × (e β − 1)%, to obtain the percent change in risk associated with one standard deviation increase in the (adjusted) variable. These quantities are reported in Table 1 . The analysis shows that SUV max and H E are strongly associated with risk of death; in that 30-35% increases in risk are associated with one standard deviation increase in these variables. Having adjusted for H E , there is little new insight into risk that is provided by the more elaborate characterizations of heterogeneity. However, the estimated effects associated with H S and H G are appreciable and could have substantial practical importance. A further analysis was carried out to identify the best subset of the variables RD, Vol, H E , H S and H G to include with age and SUV max in a proportional hazards analysis. This analysis was implemented in SAS Institute (1999) using the global score χ 2 -statistic for the model. The best model obtained only included one of the variables, the boundary-based heterogeneity, H S . The next two best models also only contained one additional variable, these being models with H G and H E . Therefore, there may well be a role for consideration of more elaborate measures of heterogeneity with sarcoma data.
DISCUSSION
We have developed refined measures of heterogeneity of glucose utilization in sarcoma. The method involves the incorporation of descriptors of the tumor surface boundary that are based on 2-D nonparametric smoothing. The procedure has been applied to a collection of image data from 179 patients. The results show that the incorporation of tumor boundary information into the definition of heterogeneity may provide a better evaluation of tumor progression than elliptical heterogeneity. However, both measures of heterogeneity are strongly correlated and it will require more data to obtain a clearer understanding of the optimal approach to characterization of heterogeneity for prognostic purposes.
